Webinars & e-learning courses All webinars

LIVE-STREAM: EXCLUSIVE ONCOLOGY VETGRUPPEN CONFERENCE

LIVE-STREAM: EXCLUSIVE ONCOLOGY VETGRUPPEN CONFERENCE
LIVE-STREAM: EXCLUSIVE ONCOLOGY VETGRUPPEN CONFERENCE

Revolutionizing Veterinary Oncology – Innovations You Can Use Today! 

Join VetGruppen Germany for an exclusive, cutting-edge event where veterinary oncology meets real-world practice. Discover the latest breakthroughs in cancer detection, treatment, and patient care—designed to elevate your clinic’s oncology expertise.

Keynote Speaker: Dr. Sue Ettinger!

We’re thrilled to welcome the renowned Dr. Sue Ettinger, who will deliver two powerhouse sessions packed with cutting-edge oncology insights! 

  • “My Favorite Cancer Tools for Everyday Practice 2025: Bringing Innovation to Your Oncology Toolbox” 
  • “Beyond Prednisone: Rethinking Lymphoma Management in General Practice” Simultaneous translation available 

 

AGENDA SATURDAY, MARCH 22, 2025 

1:00 PM – 2:30 PM Keynote by Dr. Sue Ettinger: My Favorite Cancer Tools for Everyday Practice 2025: Bringing Innovation to Your Oncology Toolbox 

  • Innovative Cancer Detection & Diagnostics 
  • Breakthrough Treatments
  • Takeaway: Discover cutting-edge tools and strategies that bring oncology innovations into everyday veterinary practice! 

2:30 PM – 2:45 PM Q&A 

2:45 PM – 3:15 PM Break 

3:15 PM – 4:45 PM Keynote by Dr. Sue Ettinger: Beyond Prednisone: Rethinking Lymphoma Management in General Practice 

  • Beyond Prednisone: Smarter Treatment Strategies 
  • Latest Treatment Options 
  • When Chemotherapy Isn't an Option 
  • Takeaway: Stay ahead with cutting-edge insights to optimize canine lymphoma treatment in everyday veterinary care! 

4:45 PM – 5:15 PM Q&A 

 

ATF-Anerkennung gemäß §§ 10, 12 der ATF-Statuten: 4 Stunden

Recorded on March 21, 2025

Speaker:

IMG_7393.jpg

Sue Ettinger

DVM, DACVIM (Oncology)

Dr. Sue Ettinger, DVM, DACVIM (Oncology), is a board-certified veterinary oncologist, international speaker, author, and vlogger. She is one of approximately 450 board-certified specialists in medical oncology in North America and currently practices at Guardian Veterinary Specialists in Brewster, NY.

She earned her veterinary degree from Cornell University College of Veterinary Medicine and completed her medical oncology residency at the Animal Medical Center in NYC in 2003.

Dr. Sue is widely recognized for her contributions to veterinary medicine. She was voted 2019 WVC Small Animal Continuing Educator of the Year and has received awards for Exceptional Doctor Performance and Public Relations Achievement. She co-authored the best-selling Second Edition of The Dog Cancer Survival Guide and frequently contributes to major veterinary publications such as Today’s Veterinary Practice, Clinician’s Brief, and DVM360. She has also co-hosted The Pet Cancer Vet podcast and is a regular guest on veterinary media platforms.

As a dedicated advocate for cancer awareness and early detection, Dr. Sue developed the “See Something, Do Something, Why Wait? Aspirate.®” initiative, encouraging early diagnosis of skin and subcutaneous tumors in pets. Her approach focuses on compassionate cancer care, aiming to improve the quality of life for pets undergoing treatment.

A native of Long Island, NY, Dr. Sue has wanted to be a veterinarian since childhood. She now lives in Westchester, NY, with her two sons and two Labrador Retrievers, Matilda and Penelope.

Booking information

Duration: 2:57 h
Speaker: Sue Ettinger
from 1
219.60 US$
(inkl. tax)

You might also be interested in

staging-the-oncology-patient.png
Laura Brockley
0:57 h

Staging the Oncology Patient

Staging is one of the most important components of oncology case management. It involves determining the extent of local disease along with the presence or absence of regional or distant metastasis. The results of staging are used to give more accurate and informed treatment options along with prognostic information for each oncology patient. Some of the biggest challenges in staging is to consider how much staging is required for each case, which are the most appropriate tests, and if the results of these tests will impact treatment options and prognosis. I will discuss this information in a case-based and evidence-based approach, focusing on some of the more common cancers including canine mast cell tumours, lymphoma, oral tumours and apocrine gland anal sac adenocarcinomas.
300x200.jpg
Momoko Ito
0:53 h

Nursing the end-stage cancer patient 

As veterinary patients age, they are more susceptible to diseases and cancer. This webinar will cover the basic cancer biology, treatment options and palliative care... 
chemotherapy-precautions-and-safety-why-how-and-what-to-do-for-nurses-1.jpeg
Momoko Ito
0:45 h

Chemotherapy Precautions and Safety - Why, How and What to do (for Nurses)

Cancer frequently affects our veterinary patients and in recent years chemotherapy has become more commonly utilised treatment. General practices are increasingly prescribing and administering chemotherapy drugs. Chemotherapy drugs are toxic to cells (cytotoxic) interfering with the normal cell life cycle which results in cell death. Cancer cells are targeted by these drugs however they are not specific for cancer cells and healthy tissue can be affected. Chemotherapy drugs are also carcinogenic, mutagenic, teratogenic and abortifacient. It is important that these drugs are handled safely. Personnel handling of chemotherapeutic drugs have been found to have increased risks of infertility, early pregnancy loss or urinary excretion of these drugs. This webinar will discuss the safety precautions necessary for handling chemotherapy agents and will focus on the recent consensus guidelines produced by the American College of Veterinary Internal Medicine (ACVIM) in January 2018 to raise awareness of risks and how we can reduce the exposure within clinics. If time permits, common side effects (neutropaenia, thorombocytopaenia and gastrointestinal side effects) caused by chemotherapy will be explained as well as precautions for handling such patients.